Gnosis by Lesaffre is launching a new version of vitaMK7® natural vitamin K2 with enhanced protection: vitaMK7® Matrix.
Ensuring the stability of menaquinone ingredients in complex finished product formulations is not a one-size-fits-all solution. Expertise is required to ensure the correct ingredient solution is provided depending on the final formulation and application.
To that end, Gnosis by Lesaffre is introducing a new version of our renowned vitaMK7® natural vitamin K2 with enhanced protection: vitaMK7® Matrix. This latest innovation is the result of a proprietary technology that protects the particles of MK-7 with no coating, no additives, and no additional ingredient.
“Stability is a constant issue facing commercial partners with the desire to create complex vitamin K2 formulations. Historically our R&D Team has been able to guide them through the process to ensure their products were stable,” says Dr Sophie Legrain-Raspaud, Global Research and Applications Director with Gnosis by Lesaffre. “With vitaMK7® Matrix, that process is now more efficient because the carrier is organized as a matrix to embed the K2 as MK-7 particles, thus leading to products hitting the market much faster.”
DISCOVER ALL OUR LATEST NEWS

Natural Probiotic Yeast Support on World Digestive Health Day
Each year on May 29, World Digestive Health Day raises global awareness about the importance of a healthy digestive system. This day serves not only as a reminder of digestive well-being, but also as a call to action—to understand better and support the millions living with gastrointestinal disorders.

Infodemiology Offers a Fresh Lens on Nutritional Yeast
Haven’t you ever wondered what consumers think about yeast? Infodemiology, an innovative social media listening approach, provides insights into how consumers perceive nutritional yeast.

K2SAC’s 4th Meeting Showcases New Clinical Insights and Emerging Talent in Vitamin K2 Research
On May 12-13, the 4th Gnosis Vitamin K2 Scientific Advisory Committee meeting convened leading experts in Greece to discuss the latest advancements in vitamin K2 research and innovation.